Australian prescribers have tasted digital convenience and are unlikely to return to their pre-pandemic levels of face-to-face engagement with pharmaceutical representatives. That’s according to an in-depth report published by AusDoc in 2021 and a follow-up pulse survey among Australian Doctor readers conducted in January 2022[i]. The report titled How a GP initiated engagement model could
With over 82% of GPs[1] and 90% of pharma sales reps, adg Rep Connect will soon become the largest and most powerful communications platform for doctors and pharmaceutical sales representatives wishing to communicate with each other. To continue to support doctors with getting access to the information they need, we are making some new changes
Being a member of the academic elite doesn’t necessarily make a good doctor, an AusDoc survey has revealed. From an experienced doctor’s perspective, high-achieving academics can face problems in practice. “Almost only the academic elite enter the system. This doesn’t necessarily make the best doctors…they are not used to failure and uncertainty and the hospital,
COVID-19 changed GP engagement permanently. A leading modelling expert explains why digital GTM channels are now essential for pharma companies wanting to reach Australian doctors.
A leading pharmaceutical company asked ADG to design a campaign encouraging GPs to follow updated treatment guidelines and build their knowledge and confidence to initiate prescriptions of its product.
GP registrars carry enormous responsibility with limited experience. AusDoc research reveals 5 practical ways pharma can support registrar confidence and build early HCP relationships.
Meet John Betsis from the Gold Coast, diagnosed with mitochondrial disease in his late teens.
AusDoc research reveals what Australian GPs actually want from pharma — 6 priority messages that cut through information overload and drive meaningful HCP engagement.
Survey uncovers what medical students need and how best to connect with them Helping medical students to succeed in their studies is a key factor in getting their attention, a recent ADG survey* has found. The survey, conducted in February 2021, asked students in their final two years of study about the tensions they face and what they need
Hologic tasked ADG to promote its leading gynaecological product to help close knowledge gaps among GPs and address both over and undertreatment for heavy menstrual bleeding.
A leading brand in the Women’s Health market tasked ADG to deliver growth and maintain profitability of the brand through a digital only plan. GPs who engaged in 4 or more Access.PLUS articles had a 14% higher prescription rate vs the market and non-engaged GPs.
The Royal College of Pathologists of Australasia (RCPA), with funding from the Australian Government Department of Health, partnered with ADG to help promote the quality use of pathology to GPs and other health professionals.